Cover image not available

Costing statement : Tocilizumab for the treatment of systemic juvenile idiopathic arthritis : Implementing NICE guidance

National Institute for Health and Clinical Excellence

Publication Data

Title Costing statement : Tocilizumab for the treatment of systemic juvenile idiopathic arthritis : Implementing NICE guidance
Alternative Title Tocilizumab for the treatment of systemic juvenile idiopathic arthritis
Author National Institute for Health and Clinical Excellence
Publisher National Institute for Health and Clinical Excellence
Publication date 0000
Publication location London

Descriptive Notes

"Technology appraisal implementation tools."

Topics

Rheumatoid arthritis in children :: Great Britain :: Cost effectiveness
Immunosuppressive agents

Catalogue Data

OBNB ID GBB586606
ISBN 10 n/a
ISBN 13 n/a
Type BibliographicResource, Book
Dewey Classification 618.927227061

ISBD

P1053 1 online resource (8 pages)
P1042 Includes bibliographical references (page 8).

Buy a copy

OBNB doesn't sell books, but you may be able to find a copy at one of these websites:

Costing statement : Tocilizumab for the treatment of systemic juvenile idiopathic arthritis : Implementing NICE guidance by National Institute for Health and Clinical Excellence. Published by National Institute for Health and Clinical Excellence. Publication and catalogue information, links to buy online and reader comments.